Cannador (Society for Clinical Research, Germany) is an oral capsule containing a whole plant extract, with standardized THC content and a CBD amount controlled to lie within a fixed narrow range with a THC:CBD ratio of about 2:1.

It has been used in several clinical trials and is a registered trademark in many countries. It has been clinically tested for reduction of muscle stiffness, spasms and associated pain in Multiple Sclerosis, for anorexia, in cancer patients, and for post-operative pain management.